Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 18 | 3 | HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS//THROMBOSIS RESEARCH | 124610 |
| 518 | 2 | ASPIRIN RESISTANCE//ASPIRIN//THROMBOSIS RESEARCH | 15555 |
| 28613 | 1 | PARTIALLY INPATIENT//ASPIRIN LIKE DEFECT OF PLATELETS//BIOSTAT EXPERT KONYA | 222 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | PARTIALLY INPATIENT | authKW | 283935 | 1% | 100% | 2 |
| 2 | ASPIRIN LIKE DEFECT OF PLATELETS | authKW | 141968 | 0% | 100% | 1 |
| 3 | BIOSTAT EXPERT KONYA | address | 141968 | 0% | 100% | 1 |
| 4 | BP DEVICE | authKW | 141968 | 0% | 100% | 1 |
| 5 | CERVICAL SPINE DISEASES | authKW | 141968 | 0% | 100% | 1 |
| 6 | CLIN INTERNAL MED 4 GASTROENTEROL | address | 141968 | 0% | 100% | 1 |
| 7 | CONGENITAL PLATELET CYCLO OXYGENASE DEFICIENCY | authKW | 141968 | 0% | 100% | 1 |
| 8 | CYCLO OXYGENASE 1 DEFICIENCY | authKW | 141968 | 0% | 100% | 1 |
| 9 | CYCLOOXYGENASE 1 PROSTAGLANDIN H SYNTHASE 1 DEFICIENCY | authKW | 141968 | 0% | 100% | 1 |
| 10 | EXOGENOUS 14C ARACHIDONIC ACID | authKW | 141968 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Medicine, General & Internal | 981 | 31% | 0% | 69 |
| 2 | Peripheral Vascular Diseases | 271 | 11% | 0% | 24 |
| 3 | Hematology | 248 | 11% | 0% | 24 |
| 4 | Endocrinology & Metabolism | 171 | 12% | 0% | 26 |
| 5 | Cardiac & Cardiovascular System | 78 | 9% | 0% | 19 |
| 6 | Pharmacology & Pharmacy | 36 | 10% | 0% | 22 |
| 7 | Pathology | 33 | 4% | 0% | 9 |
| 8 | Medicine, Legal | 30 | 1% | 0% | 3 |
| 9 | Otorhinolaryngology | 26 | 3% | 0% | 6 |
| 10 | Public, Environmental & Occupational Health | 16 | 5% | 0% | 11 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOSTAT EXPERT KONYA | 141968 | 0% | 100% | 1 |
| 2 | CLIN INTERNAL MED 4 GASTROENTEROL | 141968 | 0% | 100% | 1 |
| 3 | HACISABAN MAHALLESI | 141968 | 0% | 100% | 1 |
| 4 | KATEDRA OTOLARYNGOL ONKOL LARYNGOLOGICZNEJ | 141968 | 0% | 100% | 1 |
| 5 | KLIN HOCH ULAMBULANZ ORTHOPADIE | 141968 | 0% | 100% | 1 |
| 6 | MED BIOCHIM TISSU CONJUNCTIF CNRS GR40 | 141968 | 0% | 100% | 1 |
| 7 | MED INTERNAL MED 3RD | 141968 | 0% | 100% | 1 |
| 8 | SAMODZIELNA PRACOWNIA BADARI SERCA NACZYN | 141968 | 0% | 100% | 1 |
| 9 | UNIT LIPID DISORDERS ATHEROSCLEROSIS | 141968 | 0% | 100% | 1 |
| 10 | UWCMWELSH ADVERSE DRUG REACT EME | 141968 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 23340 | 5% | 1% | 12 |
| 2 | WIENER KLINISCHE WOCHENSCHRIFT | 15023 | 11% | 0% | 24 |
| 3 | REVUE DU PRATICIEN | 6660 | 3% | 1% | 6 |
| 4 | SOZIAL-UND PRAVENTIVMEDIZIN | 5673 | 3% | 1% | 6 |
| 5 | LABORATORNOE DELO | 4449 | 2% | 1% | 5 |
| 6 | OTO-RHINO-LARYNGOLOGIA NOVA | 4172 | 1% | 1% | 2 |
| 7 | OFFENTLICHE GESUNDHEITSWESEN | 2895 | 0% | 2% | 1 |
| 8 | PROSTAGLANDINS AND MEDICINE | 2498 | 1% | 1% | 2 |
| 9 | EXPERIMENTELLE PATHOLOGIE | 2404 | 0% | 2% | 1 |
| 10 | KLINICHESKAYA MEDITSINA | 2230 | 3% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |